Nogapendekin alfa inbakicept (NAI)

Drug identity checked against registry records

Also recorded as ANKTIVA; N-803; Nogapendekin alfa-inbakicept

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
NAI for Sepsis With Persistent LymphopeniaNCT07578558IBRXPhase 2Withdrawn2027-08-03Estimated
NAI Plus Standard of Care Compared To SOC Alone Plus Standard of Care in Critically Ill Adults With SepsisNCT07783789IBRXPhase 2Not yet recruiting2028-05-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.